[Bloomberg] Express Scripts Raises Pressure on Gilead for Drug Price
Apr 8, 2014
By Michelle Fay Cortez April 8, 2014 Express Scripts Holding Co., a… Read More
© 2024 CSRXP- All Rights Reserved
Updates
[Wall Street Journal] ‘Unsustainable for Our Country’: Express Scripts Calls Out Pricey Meds
Apr 8, 2014
By Ed Silverman April 8, 2014 Each year, Express Scripts… Read More
[Bloomberg] Gilead’s $84,000 Treatment Questioned by U.S. Lawmakers
Mar 21, 2014
By Drew Armstrong Mar. 21, 2014 Gilead Sciences Inc. (GILD) is being… Read More
[New York Times] How Much Should Hepatitis C Treatment Cost?
Mar 16, 2014
Editorial Board March 16 A new pill to treat hepatitis C raises… Read More
[Associated Press] Medical Groups Question Price Of New Hep C Drug
Mar 11, 2014
By Matthew Perrone March 11, 2014 An innovative hepatitis C drug that… Read More
[LA Times] Prices of new hepatitis C drugs are tough to swallow for insurers
Mar 9, 2014
By Chad Terhune and Eryn Brown A pair of new drugs to treat hepatitis C offer… Read More
[USA Today] Could new hepatitis C drugs bust state budgets?
Mar 3, 2014
By Michael Ollove Two new medications to treat the deadly epidemic of… Read More
[Washinton Post] Costly hepatitis drug Sovaldi rattles industry
Mar 1, 2014
By Sandhya Somashekhar When the Food and Drug Administration approved a… Read More